HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 56 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $5,000 | -83.3% | 16,054 | -64.3% | 0.00% | – |
| Q3 2019 | $30,000 | -66.7% | 44,914 | -17.4% | 0.00% | – |
| Q2 2019 | $90,000 | +5.9% | 54,369 | +60.8% | 0.00% | – |
| Q1 2019 | $85,000 | -43.7% | 33,810 | -43.0% | 0.00% | – |
| Q4 2018 | $151,000 | -41.2% | 59,340 | -24.6% | 0.00% | – |
| Q2 2018 | $257,000 | +424.5% | 78,701 | +172.2% | 0.00% | – |
| Q3 2017 | $49,000 | – | 28,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| MACKENZIE FINANCIAL CORP | 29,208 | $223,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |